Plaxvix sales still pick up steam

Last year’s sales of anticlotting drug Plavix topped the list in the domestic prescription market with 117.1 billion won, according to EDI (electronic data interchange) data released by the Health Insurance Review Agency.

Pfizer’s Norvasc and Lipitor came in second and third rank with 92.9 billion won and 73.5 billion, respectively. Four Korean drug makers plan to simultaneously launch gener...